Ameriprise’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$173M Sell
1,610,774
-493,520
-23% -$55.5M 0.04% 405
2025
Q4
$238M Buy
2,104,294
+204,010
+11% +$19.5M 0.05% 326
2025
Q3
$155M Sell
1,900,284
-98,968
-5% -$9.09M 0.04% 426
2025
Q2
$207M Buy
1,999,252
+55,297
+3% +$5.19M 0.05% 346
2025
Q1
$191M Buy
1,943,955
+13,129
+0.7% +$1.75M 0.05% 349
2024
Q4
$290M Buy
1,930,826
+290,661
+18% +$40M 0.07% 263
2024
Q3
$214M Buy
1,640,165
+296,865
+22% +$36.9M 0.05% 327
2024
Q2
$159M Sell
1,343,300
-116,159
-8% -$12.3M 0.04% 379
2024
Q1
$138M Buy
1,459,459
+322,774
+28% +$28.8M 0.04% 428
2023
Q4
$90.4M Buy
1,136,685
+280,524
+33% +$19.1M 0.03% 552
2023
Q3
$64.4M Buy
856,161
+268,280
+46% +$20M 0.02% 652
2023
Q2
$41.9M Buy
587,881
+409,566
+230% +$23.5M 0.01% 843
2023
Q1
$8.93M Sell
178,315
-6,200
-3% -$301K ﹤0.01% 1857
2022
Q4
$8.06M Sell
184,515
-10,035
-5% -$495K ﹤0.01% 1926
2022
Q3
$10.4M Sell
194,550
-4,330
-2% -$223K ﹤0.01% 1646
2022
Q2
$9.03M Sell
198,880
-5,929
-3% -$281K ﹤0.01% 1822
2022
Q1
$11.8M Sell
204,809
-100,178
-33% -$5.3M ﹤0.01% 1780
2021
Q4
$13.6M Sell
304,987
-271,886
-47% -$12.5M ﹤0.01% 1724
2021
Q3
$27.8M Sell
576,873
-429,361
-43% -$23.8M 0.01% 1045
2021
Q2
$85.4M Buy
1,006,234
+271,243
+37% +$22.3M 0.03% 580
2021
Q1
$61.7M Buy
734,991
+145,288
+25% +$12.8M 0.02% 689
2020
Q4
$44.4M Buy
589,703
+32,661
+6% +$2.06M 0.02% 791
2020
Q3
$27.6M Buy
557,042
+15,742
+3% +$692K 0.01% 912
2020
Q2
$20.8M Buy
541,300
+101,502
+23% +$3.78M 0.01% 1031
2020
Q1
$13.6M Buy
439,798
+174,945
+66% +$8.98M 0.01% 1180
2019
Q4
$14.4M Buy
264,853
+17,709
+7% +$1.08M 0.01% 1437
2019
Q3
$15.4M Buy
247,144
+118,068
+91% +$8.32M 0.01% 1343
2019
Q2
$9.73M Sell
129,076
-91,902
-42% -$6.59M ﹤0.01% 1760
2019
Q1
$17.3M Sell
220,978
-50,599
-19% -$3.38M 0.01% 1252
2018
Q4
$15.3M Buy
271,577
+28,263
+12% +$1.7M 0.01% 1244
2018
Q3
$15.3M Buy
243,314
+87,214
+56% +$4.28M 0.01% 1527
2018
Q2
$6.34M Buy
156,100
+5,377
+4% +$191K ﹤0.01% 2073
2018
Q1
$4.65M Buy
150,723
+58,935
+64% +$1.78M ﹤0.01% 2223
2017
Q4
$2.36M Sell
91,788
-10,117
-10% -$301K ﹤0.01% 2576
2017
Q3
$3.36M Sell
101,905
-1,602
-2% -$60.8K ﹤0.01% 2348
2017
Q2
$4.29M Buy
103,507
+12,613
+14% +$543K ﹤0.01% 2182
2017
Q1
$4.66M Sell
90,894
-31,087
-25% -$1.35M ﹤0.01% 2099
2016
Q4
$4.18M Buy
121,981
+7,955
+7% +$272K ﹤0.01% 2174
2016
Q3
$4.3M Buy
114,026
+2,019
+2% +$66.8K ﹤0.01% 2098
2016
Q2
$3.27M Buy
112,007
+46,614
+71% +$1.08M ﹤0.01% 2239
2016
Q1
$1.1M Sell
65,393
-2,283
-3% -$39.6K ﹤0.01% 2801
2015
Q4
$1.67M Buy
67,676
+3,100
+5% +$71.1K ﹤0.01% 2701
2015
Q3
$1.56M Sell
64,576
-46,974
-42% -$1.41M ﹤0.01% 2758
2015
Q2
$3.23M Buy
+111,550
New +$3.24M ﹤0.01% 2432

Other funds holding GKOS

Ameriprise's GKOS Position: Q1 2026 in Review

Ameriprise reduced its Glaukos (GKOS) stake by 23% in Q1 2026, selling an estimated $55.5M and leaving 1,610,774 shares worth $173M. The position accounts for 0.04% of the portfolio, ranked #405.

Ameriprise first reported a position in GKOS in Q2 2015 and has held it in 44 quarters since. The position peaked at $290M in Q4 2024. 336 funds tracked by Wall St. Rank hold GKOS as of Q1 2026.

  • Ameriprise held 1,610,774 shares of Glaukos worth $173M as of Q1 2026.
  • Ameriprise sold 493,520 Glaukos shares in Q1 2026, an estimated $55.5M.
  • Glaukos made up 0.04% of Ameriprise's portfolio in Q1 2026, its #405 holding.
  • Ameriprise first reported a position in Glaukos in Q2 2015 and has held it in 44 quarters since.
  • Ameriprise's Glaukos position peaked at $290M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Glaukos as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.